Adenosine CAS 58-61-7 Assay 99.0%-101.0% USP Standard Factory High Munditia

Description:

Nomen: Adenosine

CAS: 58-61-7

Aspectus: Crystallina pulveris alba, Odorless

Intenta: 99.0%~ 101.0% (ex sicco basis)

USP35 Standard, High Quality, Commercial Production

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum Adenosinae (CAS: 58-61-7) cum qualitate alta, vexillum USP occurrit, vexillum AJI97.Ruifu Chemical seriem supplet Nucleosidum, Nucleotidum, Acidum nucleicum.Praebere possumus terrarum traditionem, parvas et parvas quantitates in promptu.Si interest in Adenosine (CAS: 58-61-7); Please contact: alvin@ruifuchem.com 

Chemical Properties:

Nomen Adenosine
Synonyma D-Adenosine;Adenosine, Free Base;Adenocard;Triticum aestivum;9-beta-D-Ribofuranosyladenine;9-β-D-Ribofuranosyladenine;6-Amino-9β-D-Ribofuranosyl-9H Purine;6-Amino-9(β-D-Ribofuranosyl)-9H-Purine;Adenine-9-beta-D-Ribofuranoside
CAS Number 58-61-7
Stock Status In Stock, Productio Capacity 500 Tons per Year
Formulae hypotheticae C10H13N5O4
M. Pondus 267.25
Liquescens punctum 233.0~ 238.0℃
Sensitiva Air Sensitiva
Solubilitas Leviter solutum in aqua, solubile in aqua calida, in Ethanol fere Insolubile (96 percent) et in Methylene Chloride.
Solubilitas in aqua calida Prope diaphanum
Classification Nucleosides, Nucleotides, Acides Nucleicae
Brand Ruifu Chemical

Salutis Information 58-61-7:

Periculum Denunciationes 36/37/38 F 10-23
Salus Denunciationes 24/25-36/37/39-26 TSCA Ita
WGK Germania 2 HS Code* 2934993090
RTECS AU7175000 Toxicity LD50 oralis in muris: > 20gm/kg

Specifications:

Items

Signa inspectionis

Proventus

Aspectus

Crystallina pulveris alba, Odorless

Obsequitur

Lepidium sativum

IR conformis ad Reference

Obsequitur

Imprimis Rotationes [a]20/D

-68.0°~-72.0° (C=2 in 5% NaOH)

-71.7°

Liquescens punctum

233.0~ 238.0℃

235.0~ 236.0℃

Acorem vel Alkalinity

Meets Requirements

Obsequitur

Damnum in Siccatio

≤0.50%

0.04%

Metalla gravis

≤10ppm

<10ppm

Residere in Ignition

≤0.10%

0.08%

Terminus Ammoniae

≤0.0004%

<0.0004%

Terminus Chloride

≤0.007%

<0.007%

Terminus Sulfate

≤0.04%

<0.02%

Guanosine

≤0.10%

absentia

Insine

≤0.10%

0.01%

Uridine

≤0.10%

absentia

Adenine

≤0.10%

absentia

Totalis immunditias

≤0.50%

0.04%

Assay

99.0 ~ 101.0% (ex exaruit basis)

100.3%

Test Standard

USP35 Standard

Obsequitur

amni Products

Adenosine Triphosphate (ATP), Adenine, Adenylate, Adenosine Arabinose

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Lucem protege, humorem.Agentibus oxidizing fortis repugnat.

58-61-7 USP35 Modus Test:

DEFINITIO
Adenosinum continet NLT 99.0% et NMT 101.0% C10H13N5O4, in fundamento siccato computatum.
IDENTIFICATIO
• A. ABSORPTIO INFRARED <197K>: NMT 0.1%
TEMPTATIO
• ADENOSINE
Sample: 200 mg Adenosinae antea exsiccatae ad 105° pro 2h
Systema titrimetricum
(Vide Titrimetrium<541>)
Modus: Direct titration
Titrant: 0.1 N per acidum chloricum VS
Endpoint deprehensio: Potentiometric
Analysis: Solve in acidi glacialis acetici 50 mL et titrate cum 0.1 N per acidum chloricum VS.Computus centesimae Adenosinae (C10H13N5O4) in portione sumpta;
Proventus = [(V B) N F 100]/W
V = Sample titrant volumen (mL)
B = volumen titrant Blank (mL)
N = titrant normalitatis (mEq/mL)
F= aequivalentia factor: 267.25 mg/mEq
Sample W = pondus (medicamentum)
Acceptatio criteria: 99.0%-101.0% in fundamento exsiccato
• IMPURITIES
• RESIDUEON IGNIS <281>: NMT 0.1%
• METALS GRAVALIS, Methodus II <231>: NMT 10 ppm .
AMMONIAE • FINIS
Sample solutio: Suspende 0.5 g in 10 mL aquae.30 Excita s, et transi per vilem colum.LIQUET cum aqua ad XV mL diluto, et LIQUO utere.
Solutio Standard: 0.4 µg/mL Ammoni chloridi in aqua
Analysis: Ad solutionem Sampliam et solutionem Latinam adde 0.3 mL alcalini mer-potassii curic-iodidi TS, pilei tubulae test, et permitte stare pro 5 min.
Re- gulae acceptationis: Solutio Sample intensiorem colorem flavum non exhibet quam solutionis Standardi (NMT 4 ppm ammoniaci).
• FINIS CHLORIDIS
Sample solutio: Suspende 0.2 g in 10 mL aquae.Excita pro 30 s, transi per filtrum crassum, et liquamine utere.
Solutio mensurae: 2.3 µg/mL sodii chloridi in aqua
Analysis: Ad solutionem Sampli et solutionis 10 mL Vexillimae adde acidi nitrici 1 mL et 1 mL nitrati argenti TS, et singulas solutiones cum aqua diluas ad 40 mL.Patitur solutiones stare pro 5 min, a luce protectus.
Re- gulae acceptationis: Cum contra obscurum in prospectum spectat, solutio Sample non magis turbida est quam solutionem Latin (NMT 0.007% chloride).
• FINIS SULFATE
Sample solutio: Suspendite 0.75 g in 15 mL aquae.Excita pro 30 s, transi per filtrum crassum, et liquamine utere.
Solutio Standard: Adde 0.15 mL ex 0.020 Acidi sulphurici N ad 15 mL aquae.
Analysis: Solutio Sampliae et Solutio Vulgatae addunt 2 mL barii chloridi TS et 1 mL acidi hydrochlorici 3 N, solutionem unamquamque cum aqua ad 30 mL dilue, et misce.Patitur solutiones stare pro 5 min.
Re- gulae acceptationis: Solutio Sample non turbidior quam solutio Latin (NMT 0.02% sulfate).
• IMPURITIES ORGANICA
Solutio A: 6.8 g/L sulphatis potassii hydrogenii et 3.4g/L tetrabutylammonii hydrogenii sulfatis in aqua.Adpone cum 2 N potassium hydroxidum ad pH 6.5.
Solutio B: 0.1 g/L solutionis sodii azi
Mobilis pars: Solutio A et Solutio B (60:40).
Solutio idoneitatis systematis: 0.2 mg/mL singulae adenosinae et inosinae in tempore Mobili
Sample solutio: 1.0 mg/mL Adenosinae in tempore Mobili
Systema chromatographicum
(Vide Chromatographiam <621>, Ratio idoneitatis.)
Modus: LC
Detector: UV 254 nm
Columna: 4.6-mm × 25-cm;5-µm stipare L1
Fluunt rate: 1.5 mL/min
Iniectio amplitudo: 20 µL
Ratio convenientia
Exempla: Systema idoneitatem solutionem
Convenientia requisita
Resolutio: NLT 9.0 inter adenosinum et inosinum
Tendens factor: NMT 2.5
Relativum vexillum declinationis: NMT 2.0%
[Nota-chromatographa solutionis Sample, et tempus ad minimum bis retentionis temporis maioris culminis compone].
Analysis
Sample: Sample solution
Recipis cujusque immunditiae rationem in portione Adenosine sumtam;
Proventus = (rU/rT) 100
rU = apicem responsionis cuiusque immunditiae ex Sample solutione
rT = summa omnium responsionum omnium montium ex Sample solutione
Criteria acceptatio
Individuae immunditiae: NMT 0.1% singula guanosina, inosina, uridine, et NMT 0.2% adeninae
Totalis immunditiae: NMT 0.5%
IN SPECIE TESTS
• TRACTUS VEL TEMPERATURA EXCUSATIO <741>: 233°-238°
• ROTATIO OPTICALIS, Rotationis Imprimis <781S>: -68° ad -72°
Solutio test: 20 mg/mL in solutione sodium sodium (1 in 20), determinatum in exemplo ante 105° pro 2h exsiccato.
ACIDITAS VEL ALKALINITY: Suspende 1 g in 20 mL aquae dioxide-liberae.30 Excita s, et per vilem sparges colum.Ad binas singulas 10-mL filtrati portiones adde 0.1mL purpurae bromocresoli TS.
Re- gulae acceptationis: NMT 0.3 mL e 0.01 N hydroxidum sodium proferre requiritur in una portione colorem caeruleum-violaeum.NMT 0.1 mL 0.01 N. Acidum hydrochloricum in altera parte colorem luteum producere oportet.
• LOSSON EXsiccatio <731>: sicca specimen in 105℃ pro 2 h: amittit NMT 0.5% sui ponderis.
ADDITICIUS REQUISITIS
• PACKAGING AND STORAGE: Conserva in strictis, levibus vasis repugnantibus, et repone in temperatura cella moderata.
• USP Reference STANDARDS <11>
USP Adenosine RS

commoda:

1

FAQ:

www.ruifuchem.com

Applicatio:

De functione et applicatione Adenosinae (CAS: 58-61-7)
1. Adenosinum activum kinasum dapibus est.Hypoxiam myocardialem, arteriam coronariam expansionem, myocardialem contractionem auget, cardiacum output auctum et alios effectus pro angina pectoris, infarctione myocardiali acuta therapia adjuvat, sed partes eius in minori tempore servando.Usus est ad levandum angina et acuta et chronica myocardiaca infarctione et aliis morbis.Adenosinum munus physiologicum agit in systemate cardiovasculari et in multis systematibus et Institutis corporis.
2. Adenosine adhibetur in synthesi adenosine triphosphate, adenosine (ATP), adenine, adenosine, intermediis vidarabinis momenti.Adenosina maxime adhibita est in pharmaceutica industria ad fabricandum adenosinum;adenosine triphosphate;coenzyma et eius series productorum ut phosphas cyclicus adenosinus et alia medicamenta sicut materia principalis rudis.
3. Adenosinum in biochemistria, inter adenosinum triphosphatum (ATP) vel adeno-bisphosphatum (ADP) forma translationis energiae, vel ad monophosphatum cyclicum adenosinum (cAMP) pro signo transmissionis (ADP) refert.Praeterea adenosinum est neurotransmitter inhibitorium (neurotransmitter inhibitorium), somnum promovere potest.
4. Adenosinum acidum amino est.Studiorum facultates indicant anti-rugam et cuticulae facultatem.Etsi parum scriptum est de utilitate directa cutis, adenosinum magnum munus in processibus biochemicis agit.Sicut adenosinum triphosphatum (ATP) et adenosinum diphosphatum (ADP), involvitur energiae translationis, et sicut cyclicus adenosinus monophosphas (cAMP) in insigni translatione.
5. Adenosinum medicamentum antiarrhythmicum est quod accessionem supraventricularis tachycardiae convertit ad rhythmum sinus.Ponitur pro arrhythmias supraventricularis ad atrioventriculares pertinentes.

Epistulam tuam hic scribe et mitte nobis